Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.

Ding ZY, Jin GN, Wang W, Chen WX, Wu YH, Ai X, Chen L, Zhang WG, Liang HF, Laurence A, Zhang MZ, Datta PK, Zhang B, Chen XP.

Hepatology. 2014 Nov;60(5):1620-36. doi: 10.1002/hep.27273. Epub 2014 Sep 25.

PMID:
24954480
2.

Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.

Wang L, Yang H, Lei Z, Zhao J, Chen Y, Chen P, Li C, Zeng Y, Liu Z, Liu X, Zhang HT.

Oncogene. 2016 Feb 18;35(7):867-77. doi: 10.1038/onc.2015.141. Epub 2015 May 11.

PMID:
25961934
3.

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.

Xia H, Ooi LL, Hui KM.

Hepatology. 2013 Aug;58(2):629-41. doi: 10.1002/hep.26369. Epub 2013 Jun 25.

PMID:
23471579
4.

Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.

Xia L, Huang W, Tian D, Zhu H, Qi X, Chen Z, Zhang Y, Hu H, Fan D, Nie Y, Wu K.

Hepatology. 2013 Feb;57(2):610-24. doi: 10.1002/hep.26029.

PMID:
22911555
5.

Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.

Wong CC, Tse AP, Huang YP, Zhu YT, Chiu DK, Lai RK, Au SL, Kai AK, Lee JM, Wei LL, Tsang FH, Lo RC, Shi J, Zheng YP, Wong CM, Ng IO.

Hepatology. 2014 Nov;60(5):1645-58. doi: 10.1002/hep.27320. Epub 2014 Oct 2.

PMID:
25048396
6.

Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.

Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, Akcali KC, Ozturk M.

Hepatology. 2010 Sep;52(3):966-74. doi: 10.1002/hep.23769.

PMID:
20583212
7.

Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.

Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, Wang J, Lu Z, Song X, Pei T, Qin Y, Li Y, Xie C, Sun B, Shi H, Li S, Meng X, Yang G, Pan S, Zhu J, Qi S, Jiang H, Zhang Z, Liu L.

Hepatology. 2014 Nov;60(5):1659-73. doi: 10.1002/hep.27312. Epub 2014 Oct 2.

PMID:
25042864
8.

Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.

Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, Shen G, Jia H.

J Transl Med. 2017 Aug 15;15(1):176. doi: 10.1186/s12967-017-1275-8.

9.

Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.

Moon H, Ju HL, Chung SI, Cho KJ, Eun JW, Nam SW, Han KH, Calvisi DF, Ro SW.

Gastroenterology. 2017 Nov;153(5):1378-1391.e6. doi: 10.1053/j.gastro.2017.07.014. Epub 2017 Jul 20.

PMID:
28734833
10.

Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.

Dong L, Ge XY, Wang YX, Yang LQ, Li SL, Yu GY, Gao Y, Fu J.

Oral Oncol. 2013 Nov;49(11):1051-8. doi: 10.1016/j.oraloncology.2013.07.012. Epub 2013 Aug 17.

PMID:
23962790
11.

Dynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.

Andrieux G, Fattet L, Le Borgne M, Rimokh R, Théret N.

PLoS One. 2012;7(3):e33761. doi: 10.1371/journal.pone.0033761. Epub 2012 Mar 23.

12.

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

Yang H, Fang F, Chang R, Yang L.

Hepatology. 2013 Jul;58(1):205-17. doi: 10.1002/hep.26315. Epub 2013 May 14.

PMID:
23401231
14.

MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.

Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.

Hepatology. 2015 Sep;62(3):801-15. doi: 10.1002/hep.27887. Epub 2015 Jul 3.

PMID:
25953743
15.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

16.

TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.

Mu X, Lin S, Yang J, Chen C, Chen Y, Herzig MC, Washburn K, Halff GA, Walter CA, Sun B, Sun LZ.

PLoS One. 2013 May 21;8(5):e63436. doi: 10.1371/journal.pone.0063436. Print 2013.

17.

Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.

Zhang W, Sun HC, Wang WQ, Zhang QB, Zhuang PY, Xiong YQ, Zhu XD, Xu HX, Kong LQ, Wu WZ, Wang L, Song TQ, Li Q, Tang ZY.

Gastroenterology. 2012 Dec;143(6):1641-1649.e5. doi: 10.1053/j.gastro.2012.08.032. Epub 2012 Aug 23.

PMID:
22922424
18.

Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.

Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J.

Hepatology. 2012 Dec;56(6):2242-54. doi: 10.1002/hep.25907.

PMID:
22711685
19.

BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.

Tao YM, Huang JL, Zeng S, Zhang S, Fan XG, Wang ZM, Yang HX, Yuan XH, Wang P, Wu F, Luo J, Zeng DY, Shen H.

Hepatology. 2013 Jun;57(6):2326-37. doi: 10.1002/hep.26268.

PMID:
23325674
20.

JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.

Lei X, Xu JF, Chang RM, Fang F, Zuo CH, Yang LY.

Oncotarget. 2016 Jun 28;7(26):40266-40284. doi: 10.18632/oncotarget.9733.

Supplemental Content

Support Center